DaTscan is a radiopharmaceutical imaging agent that works by binding to dopamine transporters (DaT) in the brain. A specific marker for DaT, DaTscan produces images that provide visual evidence based ...
Sometimes researchers can repurpose existing technologies to dementia diagnosis. In this blog, Dr Gemma Roberts tells us more about her Alzheimer’s Society funded research at the Newcastle University ...
ST. LOUIS, April 05, 2022 (GLOBE NEWSWIRE) -- Curium announced today that its generic version of DaTscan (Ioflupane I 123 Injection) was approved on March 30, 2022, by the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results